Bank of New York Mellon Corp Sells 11,243 Shares of Astera Labs, Inc. $ALAB

Bank of New York Mellon Corp reduced its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 2.2% during the fourth quarter, HoldingsChannel reports. The firm owned 501,442 shares of the company’s stock after selling 11,243 shares during the period. Bank of New York Mellon Corp’s holdings in Astera Labs were worth $83,420,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Goldman Sachs Group Inc. lifted its holdings in shares of Astera Labs by 189.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after purchasing an additional 858,693 shares in the last quarter. Main Management ETF Advisors LLC lifted its holdings in shares of Astera Labs by 1.0% during the fourth quarter. Main Management ETF Advisors LLC now owns 18,792 shares of the company’s stock valued at $3,126,000 after purchasing an additional 192 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in shares of Astera Labs by 29.7% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 4,244 shares of the company’s stock valued at $707,000 after purchasing an additional 971 shares in the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in shares of Astera Labs by 63.7% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 473,179 shares of the company’s stock valued at $78,718,000 after purchasing an additional 184,113 shares in the last quarter. Finally, Bearing Point Capital LLC bought a new position in shares of Astera Labs during the fourth quarter valued at $3,518,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Stock Performance

ALAB stock opened at $346.33 on Tuesday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $372.37. The business’s 50-day moving average is $217.60 and its two-hundred day moving average is $173.27. The company has a market cap of $59.36 billion, a price-to-earnings ratio of 234.01, a P/E/G ratio of 4.20 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of research analyst reports. Rothschild & Co Redburn initiated coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Jefferies Financial Group reissued a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. UBS Group began coverage on Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price on the stock. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Susquehanna increased their target price on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $1,277,046.75. Following the completion of the sale, the director owned 60,134 shares of the company’s stock, valued at approximately $21,909,822.90. The trade was a 5.51% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 2,321,256 shares of company stock valued at $480,893,146. 10.40% of the stock is currently owned by corporate insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.